AHK-Cu 100mg

AHK-Cu is a research peptide consisting of the tripeptide sequence alanine-histidyl-lysine bound to a copper(II) ion. It belongs to the copper-tripeptide class of research compounds, sharing structural features with GHK-Cu — the more extensively studied copper tripeptide in cosmetic and dermatological research literature.

The compound has appeared in academic research focused on copper-peptide signalling pathways, dermal cell biology, and follicular research models. As a copper-binding peptide, it features in studies examining the role of copper-peptide complexes in cosmetic science.

AHK-Cu is supplied strictly for laboratory and research purposes. It is not intended for human or veterinary administration, consumption, medical treatment, diagnosis, or therapeutic application.

Research Background tab

AHK-Cu is structurally similar to GHK-Cu but with alanine substituted for glycine at the first position of the tripeptide sequence. This substitution gives the compound slightly different binding properties while retaining the core copper-tripeptide mechanism shared across the family.

In published research literature, AHK-Cu has been investigated alongside other copper peptides in studies examining:

• Copper-tripeptide signalling pathways
• Dermal papilla cell research
• Hair follicle biology research models
• Extracellular matrix interactions

The compound is considered an emerging research peptide. Its scientific literature is less extensive than that of GHK-Cu, with most published work concentrated in cosmetic chemistry and dermatological research contexts. Researchers exploring copper-peptide biology often work with both compounds as part of broader investigations into copper-binding tripeptide mechanisms.

AHK-Cu does not have an established clinical evidence base for any medical application and is not approved as a treatment for any condition. It is supplied as a research compound only.